|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.15 SAR | -1.47% |
|
-0.89% | +0.70% |
| 11-24 | Citi Cuts Al-Dawaa Medical's PT, Affirms Neutral Rating | MT |
| 11-12 | Riyad Capital: Al-Dawaa Medical's Retail Expansion Drives Q3 Earnings Miss | MT |
| Capitalization | 4.33B 1.15B 990M 922M 858M 1.6B 104B 1.73B 10.6B 4.17B 49.82B 4.24B 183B | P/E ratio 2025 * |
12x | P/E ratio 2026 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise value | 7.02B 1.87B 1.61B 1.5B 1.39B 2.6B 169B 2.8B 17.19B 6.76B 80.82B 6.87B 296B | EV / Sales 2025 * |
1.04x | EV / Sales 2026 * | 0.97x |
| Free-Float |
31.19% | Yield 2025 * |
5.35% | Yield 2026 * | 5.98% |
| 1 day | -1.28% | ||
| 1 week | -0.89% | ||
| Current month | +0.70% | ||
| 1 month | -6.69% | ||
| 3 months | -25.61% | ||
| 6 months | -34.74% | ||
| Current year | +0.70% |
| 1 week | 50.15 |  | 52.45 |
| 1 month | 48.7 | | 54.65 |
| Current year | 48.9 | | 52.45 |
| 1 year | 48.7 | | 87.3 |
| 3 years | 48.7 | | 121.6 |
| 5 years | 48.7 | | 121.6 |
| 10 years | 48.7 | | 121.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Corporate Officer/Principal | - | 06/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 06/06/2021 | |
Hassan Al-Somali
BRD | Director/Board Member | - | 06/06/2021 |
| Director/Board Member | - | 06/06/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -0.89% | -37.42% | -32.46% | 1.15B | |
| -2.51% | +9.43% | +140.78% | +0.74% | 28.67B | |
| -7.84% | +30.13% | +118.60% | -2.45% | 16.13B | |
| +1.53% | -2.05% | +19.06% | +26.30% | 6.51B | |
| -1.15% | +1.79% | -6.79% | +21.59% | 4.91B | |
| +1.69% | +2.80% | -6.63% | -37.94% | 3.96B | |
| -0.43% | +0.43% | -22.40% | -47.20% | 3.22B | |
| +1.13% | +3.42% | +32.25% | -47.93% | 3.06B | |
| +0.56% | -0.19% | -8.57% | +65.33% | 2.9B | |
| -3.61% | -2.71% | +47.19% | - | 1.91B | |
| Average | -1.19% | +5.82% | +27.61% | -6.00% | 7.24B | |
| Weighted average by Cap. | -2.65% | +14.37% | +83.71% | -0.54% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.77B 1.81B 1.55B 1.44B 1.34B 2.51B 163B 2.7B 16.59B 6.53B 77.99B 6.63B 286B | 6.93B 1.85B 1.59B 1.48B 1.37B 2.56B 167B 2.76B 16.97B 6.68B 79.78B 6.79B 292B |
| Net income | 362M 96.54M 82.84M 77.13M 71.78M 134M 8.72B 144M 887M 349M 4.17B 355M 15.28B | 396M 106M 90.69M 84.44M 78.58M 147M 9.54B 158M 971M 382M 4.56B 388M 16.72B |
| Net Debt | 2.69B 718M 616M 574M 534M 996M 64.81B 1.07B 6.6B 2.59B 31B 2.64B 114B | 2.41B 643M 551M 513M 478M 892M 58.01B 961M 5.9B 2.32B 27.75B 2.36B 102B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 50.15 ﷼ | -1.47% | 58,615 |
| 14/01/26 | 50.90 ﷼ | -1.36% | 188,136 |
| 13/01/26 | 51.60 ﷼ | +0.29% | 189,047 |
| 12/01/26 | 51.45 ﷼ | -0.48% | 98,813 |
| 11/01/26 | 51.70 ﷼ | +1.97% | 126,710 |
Delayed Quote Saudi Arabian S.E., January 15, 2026 at 11:39 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4163 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition